cagrilintide and tirzepatide blend (10mg vials) Adding Cagrilintide to Tirzepqtide cagrilintide tirzepatide blend vs vs

Each 10 mg vial covers 2 injections (5 mg each), so the 4 injection protocol uses 2 vials

International variations in regulatory status can create confusion and may limit access to these therapies in certain jurisdictions

Is this a supplement

i) Primary Pharmacological Actions of 5-Amino-1MQ: No It is not a neurotransmitter agonist 5-Amino-1MQ does not bind to or activate any known: Dopamine receptors Serotonin (5-HT) receptors GABAA or GABAB Cholinergic or adrenergic receptors Primary Mechanism of Action Inhibition of NNMT (Nicotinamide N-Methyltransferase) Main action : Inhibits NNMT, an enzyme that methylates nicotinamide (vitamin B3 derivative)